Showing results (641-650 of 1,837) with videos related to

Sort By:
Pageof 184
ESMO Open|June 26, 2022
Human papillomavirus infection and lung adenocarcinoma: special benefit is observed in patients treated with immune checkpoint inhibitorsL Rojas, D Mayorga, A Ruiz-Patiño, et al.
ESMO Open|June 26, 2022
Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanomaF Janku, S Bauer, K Shoumariyeh, et al.
ESMO Open|May 30, 2021
COVID-19 epidemic strongly affected cancer research in Italy: a survey of the Italian Cancer Society (SIC)F Bianchi, E Dama, F Di Nicolantonio, et al.
ESMO Open|July 4, 2021
Outcome of immune checkpoint inhibitors in metastatic renal cell carcinoma across different treatment linesI Resch, A Bruchbacher, J Franke, et al.
ESMO Open|June 17, 2022
Cancer diagnosis in Catalonia (Spain) after two years of COVID-19 pandemic: an incomplete recoveryJ Ribes, L Pareja, X Sanz, et al.
ESMO Open|June 17, 2022
Setting the international research agenda for sarcoma together with patients and carers: first results of the Sarcoma Patient EuroNet (SPAEN) priority setting partnershipO Husson, C Drabbe, K Schuster, et al.
ESMO Open|July 5, 2021
Sacituzumab govitecan and trastuzumab deruxtecan: two new antibody-drug conjugates in the breast cancer treatment landscapeE Adams, H Wildiers, P Neven, et al.
ESMO Open|September 24, 2020
Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancerNoelia Tarazona, Francisco Gimeno-Valiente, Valentina Gambardella, et al.
ESMO Open|September 24, 2020
Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancerSamantha O Perakis, Sabrina Weber, Qing Zhou, et al.
ESMO Open|November 14, 2020
Bratislava Statement: consensus recommendations for improving pancreatic cancer careJoan Prades, Dirk Arnold, Thomas Brunner, et al.
Pageof 184